# Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation

Study · id `cardio:ct-nct07036965` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07036965](<https://clinicaltrials.gov/study/NCT07036965>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07036965

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 292 participants.

## Technical summary

Registry record NCT07036965. Randomized; no masking; primary purpose treatment. Start 2025-06-30 (anticipated); primary completion 2027-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 292 participants (planned count; ClinicalTrials.gov record NCT07036965, source copy `cardio:ctgov-nct07036965-2025-06-25`, retrieved 2026-10-26)
- Planned start: 2025-06-30 (anticipated) (ClinicalTrials.gov record NCT07036965, source copy `cardio:ctgov-nct07036965-2025-06-25`, retrieved 2026-10-26)
- Primary completion: 2027-07-30 (anticipated) (ClinicalTrials.gov record NCT07036965, source copy `cardio:ctgov-nct07036965-2025-06-25`, retrieved 2026-10-26)
- Completion: 2031-06-30 (anticipated) (ClinicalTrials.gov record NCT07036965, source copy `cardio:ctgov-nct07036965-2025-06-25`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07036965, source copy `cardio:ctgov-nct07036965-2025-06-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07036965-2025-06-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation
- Acronym: COMBINATION 2P
- Condition: Atrial Fibrillation (AF)
- Intervention (Device): CardiPulse
- Intervention (Device): FaraPulse
- Lead sponsor: Hangzhou Dinova EP Technology Co., Ltd
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Hangzhou Dinova EP Technology Co., Ltd (`cardio:org-hangzhou-dinova-ep-technology-co-ltd`)

## Provenance

Content hash: fc8a7aaca45d0f640c6657572e30f177696e69b2f5fca49c1b5ca8739c860955
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
